Nasal Bleeding Recruiting Phase 4 Trials for Bevacizumab (DB00112)

Also known as: Epistaxis / Nose Bleeds / Nosebleeds / Haemorrhage nasal / Bleeding from nose / Nosebleed / Hemorrhage nasal / Hemorrhage from nose / Bleeding nose / Nose bleed

IndicationStatusPhase
DBCOND0076797 (Nasal Bleeding)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02389959Intranasal Bevacizumab for HHT-Related EpistaxisTreatment